New Drug Review: Spravato - Drug Topics

Submitted by Anonymous (not verified) on Mon, 06/10/2019 - 07:00

New Drug Review: Spravato  Drug TopicsBoth responder and remitter patients experienced a statistically significant longer time to relapse with esketamine compared to the placebo.